IGFBP-2: an important regulator of insulin-like growth factor action in human lung tumours?
Reeve
J G
JG
Medical Research Council Clinical Oncology and Radiotherapeutics Unit, Medical Research Council Centre, Cambridge, UK.
Schwander
J
J
Bleehen
N M
NM
D000230:Adenocarcinoma / Q000378:metabolism; D002352:Carrier Proteins / Q000502:physiology*; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006801:Humans; D018971:Insulin-Like Growth Factor Binding Protein 2; D007334:Insulin-Like Growth Factor I / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D007335:Insulin-Like Growth Factor II / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D008175:Lung Neoplasms / Q000378:metabolism*; D017451:Receptors, Somatomedin / Q000378:metabolism; D013002:Somatomedins / Q000378:metabolism*; D014407:Tumor Cells, Cultured
D002352:Carrier Proteins; D004273:DNA, Neoplasm; D018971:Insulin-Like Growth Factor Binding Protein 2; D017451:Receptors, Somatomedin; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II